|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBOOKCENTRAL_ocn257839542 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnunnnuuuuu |
008 |
080926s2008 sz ak obt 001 0 eng d |
040 |
|
|
|a UAB
|b eng
|e pn
|c UAB
|d CDX
|d VRC
|d N$T
|d EBLCP
|d IDEBK
|d OCLCQ
|d MHW
|d E7B
|d OCLCQ
|d FVL
|d OCLCQ
|d OCLCA
|d OCLCQ
|d NLGGC
|d YDXCP
|d OCLCQ
|d AZK
|d COCUF
|d MOR
|d PIFAG
|d ZCU
|d MERUC
|d OCLCQ
|d OCLCA
|d OCLCO
|d U3W
|d OCLCA
|d OCLCF
|d STF
|d WRM
|d NRAMU
|d ICG
|d VT2
|d AU@
|d OCLCO
|d OCLCQ
|d WYU
|d OCLCA
|d TKN
|d OCLCO
|d DKC
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
019 |
|
|
|a 319432269
|a 748588157
|a 764509509
|a 961550511
|a 962621242
|a 1058129841
|a 1064767846
|
020 |
|
|
|a 9789241547581
|
020 |
|
|
|a 9241547588
|
020 |
|
|
|a 9789240683532
|q (electronic bk.)
|
020 |
|
|
|a 9240683534
|q (electronic bk.)
|
029 |
1 |
|
|a AU@
|b 000044594930
|
029 |
1 |
|
|a CDX
|b 10149170
|
029 |
1 |
|
|a DEBBG
|b BV044133788
|
029 |
1 |
|
|a NZ1
|b 13069032
|
029 |
1 |
|
|a NZ1
|b 13329841
|
029 |
1 |
|
|a NZ1
|b 13859405
|
035 |
|
|
|a (OCoLC)257839542
|z (OCoLC)319432269
|z (OCoLC)748588157
|z (OCoLC)764509509
|z (OCoLC)961550511
|z (OCoLC)962621242
|z (OCoLC)1058129841
|z (OCoLC)1064767846
|
050 |
|
4 |
|a RA644.T7
|
060 |
|
4 |
|a WF 310
|b G3468 2208
|
072 |
|
7 |
|a MED
|x 062000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.995061
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Guidelines for the programmatic management of drug-resistant tuberculosis :
|b emergency update 2008 /
|c Steering Group, Ernesto Jaramillo [and others].
|
250 |
|
|
|a Emergency update.
|
260 |
|
|
|a Geneva :
|b World Health Organization, Stop TB Dept.,
|c ©2008.
|
300 |
|
|
|a 1 online resource (xxi, 247 pages) :
|b illustrations, forms
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
380 |
|
|
|a Bibliography
|
500 |
|
|
|a Title from title screen (viewed September 26, 2008).
|
500 |
|
|
|a "WHO/HTM/TB/2008.402."
|
504 |
|
|
|a Includes bibliographical references and index.
|
536 |
|
|
|a Funded by the UK Department for International Development and the United States Agency for International Development.
|
505 |
0 |
|
|a Background information on DR-TB -- Framework for effective control of DR-TB -- Political commitment and coordination -- Definitions : case registration, bacteriology and treatment outcomes -- Case-finding strategies -- Laboratory aspects -- Treatment strategies for MDR-TB and XDR-TB -- Mono-resistant and poly-resistant strains -- Treatment of DR-TB in special conditions and situations -- DR-TB and HIV infection -- Initial evaluation, monitoring of treatment and management of adverse effects -- Treatment delivery and community-based DR-TB support -- Management of patients after MDR-TB treatment failure -- Management of contacts of MDR-TB patients -- Drug resistance and infection control -- Human resources : training and staffing -- Management of second-line antituberulosis drugs -- Category IV recording and reporting system -- Managing DR-TB through patient-centred care -- Appendices.
|
520 |
|
|
|a "The emergence of extensively drug-resistant strains of tuberculosis, especially in countries with a high prevalence of human immunodeficiency virus, is a serious threat to global public health and jeopardizes efforts to effectively control the disease. This publication offers updated recommendations for the diagnosis and management of drug-resistant tuberculosis in a variety of geographical, economic and social settings, and the recording of data that enables the monitoring and evaluation of programs"--Publisher's description
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Multidrug-resistant tuberculosis
|x Chemotherapy.
|
650 |
|
0 |
|a Multidrug-resistant tuberculosis
|x Prevention.
|
650 |
|
0 |
|a Antitubercular agents.
|
650 |
|
0 |
|a HIV infections
|x Chemotherapy.
|
650 |
|
0 |
|a Comorbidity
|x Treatment.
|
650 |
|
0 |
|a Highly active antiretroviral therapy.
|
650 |
|
2 |
|a Tuberculosis, Multidrug-Restant
|x drug therapy
|
650 |
|
2 |
|a Tuberculosis, Multidrug-Restant
|x prevention & control
|
650 |
|
2 |
|a Antitubercular Agents
|x administration & dosage
|
650 |
|
2 |
|a HIV Infections
|x drug therapy
|
650 |
|
2 |
|a Antiretroviral Therapy, Highly Active
|
650 |
|
6 |
|a Tuberculose multirésistante
|x Chimiothérapie.
|
650 |
|
6 |
|a Antituberculeux.
|
650 |
|
6 |
|a Infections à VIH
|x Chimiothérapie.
|
650 |
|
6 |
|a Comorbidité
|x Traitement.
|
650 |
|
6 |
|a Traitement antirétroviral hautement actif.
|
650 |
|
7 |
|a MEDICAL
|x Oncology.
|2 bisacsh
|
650 |
|
7 |
|a Antitubercular agents
|2 fast
|
650 |
|
7 |
|a Highly active antiretroviral therapy
|2 fast
|
650 |
|
7 |
|a HIV infections
|x Chemotherapy
|2 fast
|
700 |
1 |
|
|a Jaramillo, Ernesto.
|
710 |
2 |
|
|a Stop TB Initiative (World Health Organization)
|
710 |
1 |
|
|a Great Britain.
|b Department for International Development.
|
710 |
1 |
|
|a United States.
|b Agency for International Development.
|
758 |
|
|
|i has work:
|a Guidelines for the programmatic management of drug-resistant tuberculosis (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGHdhwKMhXwWmwCkFpkgPP
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|t Guidelines for the programmatic management of drug-resistant tuberculosis.
|b Emergency update.
|d Geneva, Switzerland : World Health Organization [Stop TB Dept.], ©2008
|z 9789241547581
|z 9241547588
|w (OCoLC)277203775
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=420990
|z Texto completo
|
938 |
|
|
|a Coutts Information Services
|b COUT
|n 10149170
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL420990
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10277793
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 267642
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 3019735
|
994 |
|
|
|a 92
|b IZTAP
|